Suchergebnisse - "*Coronavirus"

PubPharm (10.092)

31

A longitudinal study of risk and protective factors for symptoms of adjustment disorder during the COVID-19 pandemic

enthalten in: European journal of psychotraumatology | 2024

von Lotzin, A. | Stahlmann, K. | Acquarini, E. | +22

32

Nanoparticle vaccines based on the receptor binding domain of porcine deltacoronavirus elicit robust protective immune responses in mice

enthalten in: Frontiers in immunology | 2024

von Wang, Y. | Song, J. | Deng, X. | +9

33

Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19 : a longitudinal cohort study

enthalten in: The Lancet. Microbe | 2024

von Guo, L. | Zhang, Q. | Gu, X. | +21

34

Enhanced portable detection for Sars-CoV-2 utilizing DNA tetrahedron-tethered aptamers and a pressure meter

enthalten in: Analytical methods : advancing methods and applications | 2024

von Yu, X. | Wang, Y. | Wang, K. | +5

35

In vitro biological evaluation and in silico insights into the antiviral activity of standardized olive leaves extract against SARS-CoV-2

enthalten in: PloS one | 2024

von Majrashi, T. | El Hassab, M. | Mahmoud, S. | +6

36

Effect of SARS-CoV-2 S protein on the proteolytic cleavage of the epithelial Na+ channel ENaC

enthalten in: PloS one | 2024

von Magaña-Ávila, G. | Moreno, E. | Plata, C. | +9

37

Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model

enthalten in: Frontiers in immunology | 2024

von Jacob, I. | Gemmiti, A. | Xiong, W. | +5

UpdateOf: bioRxiv. 2023 Apr 03;:. - PMID 37066146

38

Progress of SARS-CoV-2 Main protease peptide-like inhibitors

enthalten in: Chemical biology & drug design | 2024

von Liu, X. | Ren, X. | Hua, M. | +9

39

Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils

enthalten in: Cells | 2024

von Degenfeld-Schonburg, L. | Sadovnik, I. | Smiljkovic, D. | +10

40

Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection

enthalten in: Frontiers in immunology | 2024

von Liu, S. | Chen, H. | Chen, X. | +5